Sakamoto et al. presented a K-Ras (G12D) inhibitory bicyclic peptide KS-58 that presented anticancer activity against mouse tumors derived from the colorectal cancer cell line CT26 stably expressing KRAS G12D [76]. Here, KRAS is linked to colorectal cancer.